Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dynamic Medical Technologies's Days Sales Outstanding for the
three
months ended in Dec. 2025 was 65.78.
Dynamic Medical Technologies's Days Inventory for the
three
months ended in Dec. 2025 was 111.44.
Dynamic Medical Technologies's Days Payable for the
three
months ended in Dec. 2025 was 18.46.
Therefore, Dynamic Medical Technologies's Cash Conversion Cycle (CCC) for the
three
months ended in Dec. 2025 was 158.76.
Dynamic Medical Technologies (ROCO:4138) Cash Conversion Cycle Explanation
Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.
Be Aware
CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.
The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.
Dynamic Medical Technologies Cash Conversion Cycle Related Terms
Dynamic Medical Technologies Cash Conversion Cycle Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dynamic Medical Technologies Cash Conversion Cycle Chart
ROCO:4138 vs ABT, SYK, MDT: Cash Conversion Cycle Comparison
For the Medical Devices subindustry, Dynamic Medical Technologies's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dynamic Medical Technologies Cash Conversion Cycle vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Dynamic Medical Technologies's Cash Conversion Cycle distribution charts can be found below:
* The bar in red indicates where Dynamic Medical Technologies's Cash Conversion Cycle falls into.
Dynamic Medical Technologies Cash Conversion Cycle Calculation
Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.
Cash Conversion Cycle is one of several measures of management effectiveness.
Dynamic Medical Technologies's Cash Conversion Cycle for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dynamic Medical Technologies (ROCO:4138) has a Cash Conversion Cycle of 158.76 as of Dec. 2025. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Dynamic Medical Technologies and its competitors.
Is Dynamic Medical Technologies' Cash Conversion Cycle too high?
Dynamic Medical Technologies' current Cash Conversion Cycle is 158.76. The Medical Devices & Instruments industry median Cash Conversion Cycle is 158.14. Dynamic Medical Technologies' value of 158.76 is 0.4% above this industry median. Overall, Dynamic Medical Technologies has a GF Score™ of 78/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dynamic Medical Technologies' Cash Conversion Cycle compare to ABT and SYK?
Dynamic Medical Technologies' Cash Conversion Cycle of 158.76 can be compared against companies in the Medical Devices & Instruments industry. The industry median Cash Conversion Cycle is 158.14. Dynamic Medical Technologies' value of 158.76 is 0.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Conversion Cycle for a Medical Devices & Instruments company?
The median Cash Conversion Cycle among Medical Devices & Instruments companies is 158.14, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Cash Conversion Cycle significantly above this median, while those in the bottom quartile fall well below. However, Cash Conversion Cycle should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dynamic Medical Technologies's current Cash Conversion Cycle of 158.76 is 0.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Conversion Cycle mean?
A high Cash Conversion Cycle can signal that a stock is expensive relative to its fundamentals. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Dynamic Medical Technologies and its competitors. For the Medical Devices & Instruments industry, the median Cash Conversion Cycle is 158.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dynamic Medical Technologies's current Cash Conversion Cycle is 158.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dynamic Medical Technologies stock overvalued right now?
Based on GuruFocus' analysis, Dynamic Medical Technologies (ROCO:4138) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$74.17, compared to a current price of NT$50.90 — trading 31.4% below its estimated fair value. The current Cash Conversion Cycle is 158.76 and 0.4% above the Medical Devices & Instruments industry median of 158.14. Dynamic Medical Technologies' overall GF Score™ is 78/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Conversion Cycle calculated?
Cash Conversion Cycle is calculated from a company's financial statements. For Dynamic Medical Technologies (ROCO:4138), the current Cash Conversion Cycle is 158.76 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dynamic Medical Technologies (ROCO:4138) Overvalued in 2026?
Based on GuruFocus' analysis, Dynamic Medical Technologies stock appears to be undervalued.
The current stock price of NT$50.90 is trading 31.4% below its estimated GF Value™ of NT$74.17.
GuruFocus considers Dynamic Medical Technologies to be Significantly Undervalued.
Key valuation signals for ROCO:4138:
Cash Conversion Cycle: 158.76
GF Value™: NT$74.17 vs. price of NT$50.90 (31.4% below fair value)
Industry Position: 0.4% above the Medical Devices & Instruments median
No single metric tells the full story. See the ROCO:4138 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dynamic Medical Technologies Inc is engaged in the sales, maintenance, and integrated marketing of aesthetic lasers and light-based equipment. The company's product line includes aesthetic medical devices, body contouring devices, dermal fillers, and cosmeceuticals. The reportable segments after the adjustment are the Medical equipment trading segment and the Beauty channel segment. The Medical equipment trading segment includes selling, leasing, and repairing medical aesthetic equipment and selling the medical aesthetic consumables and cosmetic products. The Beauty channel segment generates revenues from the sale of lifestyle beauty products and treatments at physical store, as well as the sale of medical aesthetic products.
78GF Score
Get the complete analysis for ROCO:4138
Cash Conversion Cycle is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4138 has been successfully added to your 
